GEN Exclusives

More »

GEN News Highlights

More »
Feb 21, 2007

King Pharmaceuticals’ Facility to Manufacture Syphilis Drug Approved

  • The FDA approved King Pharmaceuticals’ new manufacturing and production facility in Rochester, MI, for its Bicillin® product line.

    According to the company, the recent Sexually Transmitted Diseases Treatment Guidelines issued in 2006 by the CDC recommends penicillin G as the preferred treatment of all stages of syphilis. Bicillin L-A, administered via deep intramuscular injection, has been used for more than 60 years to cure syphilis and prevent sexual transmission, notes Eric J. Bruce, chief technical operations officer, King Pharmaceuticals.”

    To streamline the ease and use of Bicillin L-A, continues Bruce, King is now using the Becton Dickinson Hypack™ Luer-Lok™ syringe system with the Eclipse™ safety-cover needle.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?